我国结核病防治面临三大新挑战


我国结核病防治面临三大新挑战

 
 
 
 
 

我国结核病防治面临三大新挑战 
2009年09月11日 20:05:17  来源:新华网 
    新华网北京9月11日电(记者周婷玉)当前我国结核病防治面临三大新挑战,分别是流动人口结核病防治、耐多药结核病防治、结核菌和艾滋病病毒双重感染防治。

    这是记者于正在召开的第二届国际防痨和肺部疾病联合会亚太区学术大会上获悉的。

    卫生部疾控局副局长肖东楼介绍,我国结核病患病率近年呈逐年下降趋势,死亡率明显下降,但目前我国结核病疫情仍然很严重,感染结核菌的人口基数大,发病率下降缓慢,是耐多药结核病患者数最多的国家之一。

    全国结核病耐药性基线调查结果显示,我国肺结核病人中耐多药率为8.32﹪,广泛耐药率为0.68﹪,估算有耐多药肺结核患者12万例,约占全球的五分之一。

    肖东楼表示,针对三大挑战,我国已经根据国家结核病防治规划行动计划,开展了相应的试点工作。

    另据了解,我国结核病防治在人员队伍、防治经费等方面还存在问题。各级结核病防治机构存在不同程度防治专业人员数量不足的现象,部分开设门诊的结核病防治机构从事结核病诊断的医生没有临床执业医师资格。

    在防治经费方面,全国基本结核病控制工作所需经费仍然有缺口,部分地区防治工作主要依靠国际援助项目和中央经费支持,尚未全面建立可持续发展的经费投入机制。

    “第二届国际防痨和肺部疾病联合会亚太区学术大会”于2009年9月9日至12日在北京举行。会议的主题为“耐药结核病的预防和控制”,与会人员主要就“耐多药结核病”、“结核病/艾滋病双重感染”等领域进行交流与讨论。

    这次大会由中国防痨协会承办,同时也是2009年中国防痨协会学术会议。第三届国际防痨和肺部疾病联合会亚太区学术大会将于2011年在中国香港举行。
 
TB control in China face three major new challenges
September 11, 2009 20:05:17 Source: Xinhua
     Xinhua Beijing September 11 (Xinhua Zhou Ting-yu) At present, China faces three major challenges of TB prevention and control, namely the mobile population in TB prevention and treatment of MDR-TB prevention and treatment of TB and HIV dual infection control.

     This reporter was being held in the second session of the International Union Against Tuberculosis and Lung Disease Asia Pacific Region Academic Assembly was informed of.

     Deputy Secretary for the Ministry of Health Disease Control Xiao Dong F, China's prevalence rate of TB has fallen steadily in recent years, the mortality rate decreased significantly, but China's current TB epidemic is still very serious, infection of tuberculosis of the large population base, the slow decline in incidence is the number of MDR-TB patients one of the largest.

     National Tuberculosis Drug Resistance baseline survey results show that our multi-drug resistant tuberculosis patients in the rate of 8.32%, extensively drug-resistant rate of 0.68%, estimation of multi-drug resistant tuberculosis patients 120,000 cases, accounting for about one-fifth of the world.

     Xiao Dong House said that for the three major challenges, China has tuberculosis control program in accordance with national plans of action to carry out the corresponding experiment.

     It is understood that the ranks of China's TB prevention and control of personnel, control expenses and other problems that still exist. TB prevention and control institutions at all levels of prevention and control to varying degrees the number of shortage of professionals, some clinic TB prevention and control institutions engaged in medical diagnosis of TB is not eligible for clinical practitioners.

     In the prevention and treatment funding, the national requirements for basic TB control efforts there are still gaps in prevention and treatment work in some areas mainly rely on international aid projects and the central financial support, has not yet fully established mechanisms for sustainable funding for development.

     "Second session of the International Union Against Tuberculosis and Lung Disease Association of Asia-Pacific Academic Conference" on September 9, 2009 to 12 in Beijing. The conference theme is "Prevention and control of drug-resistant TB," the participants are mainly on the "multi-drug resistant TB", "TB / HIV dual infection" and other areas of exchange and discussion.

     Tuberculosis Association, the Chinese and the Congress on national defense contractors, but also anti-tuberculosis association in 2009 academic conference. The Third International Union Against Tuberculosis and Lung Disease Asia Pacific Academic Conference will be held in Hong Kong, China in 2011.
 

 
 
 
 
 

[ 作者:佚名    转贴自:本站原创    点击数:196    更新时间:2009-9-12    文章录入:nnb ]

 

艾滋病或不再是绝症

价值中国网网友关注“发明艾滋病新药免费救治征集媒体见证人”

艾滋病早期治疗是康复与延长30~60年生命的保障

鸡尾酒疗法并非万能,抗药性与毒副作用导致联合疗法与中药疗法应用的迫切性

呼吁救治艾滋,关注化学新药

康生丹配合西药治疗AIDS总结

艾滋病“感染”、“免疫”与“营养”三关各期施治研究

康生丹四代新药,化学名—三合皂甙分类引述
 

艾滋病免疫重建的重要意义是挽救生命的根本 

从食品植物研究开发的治疗艾滋病新药三合皂甙〔康生丹四代〕介绍  

从食品植物研究开发的治疗艾滋病新药三合皂甙  

从食品植物研究开发的治疗艾滋病新药介绍  

艾滋病的中药  

论HIV不是AIDS的病因机制 

康生丹颗粒简介 

美国营养学家推崇“抗炎饮食”同于中医之食疗 

康生丹颗粒基础研究 

艾滋病预防及国外食疗研究 

艾滋病感染者能活多久 

专家:艾滋病早治疗能多活30年以上“隐形”感染者进入晚期才被确诊 

T细胞、T细胞亚群、 调节性(或抑制性)T细胞在艾滋病康复中的研究 

你知道为什么害怕“艾滋病”这三个字么?艾滋病不同感染期症状 

康生丹颗粒〈ksd〉对免疫抑制模型小鼠免疫功能影响实验研究-公布 

食疗与艾滋病研究-康生丹颗粒〈一〉 

艾滋病未来康复的动向分析 

艾滋病人的药膳 

首次公布康生丹提高艾滋病患者CD4的图片